Advantages of Self-assembled Nano Peptide Hydrogels in Biological Tissue Engineering.
Tian A., Xue J., Sun N.
Laboratory Study, published in Curr Protein Pept Sci (2022) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Curr Protein Pept Sci (2022)
- Country
- United Arab Emirates
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 35718957
- DOI
- 10.2174/1389203723666220617093402
- Citations
- 2
Abstract (original English)
With the development of tissue engineering research, biological scaffolds have been widely studied and applied in the field of regenerative medicine. Self-assembling nanopeptide hydrogels have good biocompatibility, and their seed cells can be used for their biological activities and have no toxic side effects. The products can be absorbed and degraded by the organism and have great advantages in tissue engineering and regenerative medicine. Studies have shown that the self-assembled nano peptide hydrogel and adipose-derived mesenchymal stem cells (ADMSCs) mixed solution are "biological ink". 3D related biological printing technology can be used to print related tissue models and induce ADMSCs to differentiate into blood vessels. It is further illustrated that the use of self-assembled nano peptide hydrogel scaffolds to load stem cells has a good application prospect in stem cell transplantation and 3D biological printing.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.